Who owns Immunomedics?

Key details on Immunomedics (Ticker: IMMU)

Who owns Immunomedics?

Is IMMU a good stock to own? Find out who bought Immunomedics, who sold Immunomedics (IMMU) stock, and who holds a large position in Immunomedics.

Fund Name Number of Shares Share Valuation As Of
FMR 13.12M $40.29M Dec. 31, 2015
J.P. Turner & Co Capital Mnagement 4.29M $7.37M Sept. 30, 2015
Longwood Capital Partners 3.96M $12.17M Dec. 31, 2015
OrbiMed Advisors 3.80M $11.67M Dec. 31, 2015
BlackRock Fund Advisors 3.69M $11.33M Dec. 31, 2015
Balyasny Asset Management 3.58M $10.98M Dec. 31, 2015
Vanguard 3.44M $10.57M Dec. 31, 2015
BlackRock Institutional Trust Company, N.A. 2.74M $8.42M Dec. 31, 2015
WCM Investment Management 1.99M $8.09M June 30, 2015
State of Wisconsin Investment Board 1.50M $6.09M June 30, 2015
S.A.C. Capital Advisors 1.40M $6.43M Dec. 31, 2013
Sigma Capital Management 1.38M $8.51M Sept. 30, 2013
SUSQUEHANNA INTERNATIONAL 1.37M $4.22M Dec. 31, 2015
STATE STREET CORPORATION 1.31M $4.03M Dec. 31, 2015
Perceptive Advisors 1.30M $5.28M June 30, 2015
NORTHERN TRUST 1.08M $3.31M Dec. 31, 2015
Deerfield Management Company 1.07M $3.30M Dec. 31, 2015
RA Capital Management 1000000 $3.65M June 30, 2014
Pine River Capital Management 875000 $2.11M March 31, 2013
Marshall Wace 857062 $2.63M Dec. 31, 2015
First Light Asset Management 850757 $2.61M Dec. 31, 2015
Technical Financial Services 782459 $3.76M Dec. 31, 2014
PanAgora Asset Management 640902 $1.97M Dec. 31, 2015
GOLDMAN SACHS 591309 $1.82M Dec. 31, 2015
Geode Capital Management 562750 $1.73M Dec. 31, 2015
SPHERA FUNDS MANAGEMENT 550000 $2.01M June 30, 2014

Who sold Immunomedics?

Fund Name Date Sold Number of Shares Sold Share Valuation
Candriam Luxembourg S.C.A. Dec. 31, 2014 625000 $3.00M